Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers.
paper
Cited
Public
Unavailable
- Authors
- Smith, S S; O'Hara, B F; Persico, A M; Gorelick, D A; Newlin, D B; Vlahov, D; Solomon, L; Pickens, R; Uhl, G R
- Year
- 1992
- Journal
- Archives of general psychiatry
- PMID
- 1355337
- DOI
- 10.1001/archpsyc.1992.01820090051009
Alcoholics are more likely than nonalcoholics to display the Taq I A1 restriction fragment length polymorphism of the D2 dopamine receptor gene, according to four of six studies that examined alcoholics and controls. The current study examines whether the association observed in alcoholism might extend to other addictive substances by examining D2 dopamine receptor Taq I A and B restriction fragment length polymorphisms in polysubstance users and controls free of significant substance use. We hypothesized a stronger association for the B1 restriction fragment length polymorphism since it lies closer to dopamine receptor protein coding and 5' regulatory regions. Heavy polysubstance users and subjects with DSM-III-R psychoactive substance use diagnoses displayed significantly higher Taq I B1 frequencies than control subjects; Taq I A1 results for these comparisons were less robust. These results are consistent with a role for a D2 dopamine receptor gene variant marked by these restriction fragment length polymorphisms in enhanced substance abuse vulnerability.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Catechol-O-methyltransferase and dopamine receptor D4 gene variants: Possible association with substance abuse in Bangladeshi male. | Sonia JA et al. | — | 2021 | → |
| Pre-clinical models of reward deficiency syndrome: A behavioral octopus. | Gondré-Lewis MC et al. | — | 2020 | → |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | — | 2020 | → |
| DRD2 and ANKK1 genes associate with late-onset heroin dependence in men. | Tsou CC et al. | — | 2019 | → |
| Explaining Excessive Weight Gain during Early Recovery from Addiction. | Gottfredson NC et al. | — | 2019 | → |
| The dopamine D2 receptor mediates approach-avoidance tendencies in smokers. | Zlomuzica A et al. | — | 2018 | → |
| Polymorphisms in dopaminergic system genes; association with criminal behavior and self-reported aggression in violent prison inmates from Pakistan. | Qadeer MI et al. | — | 2017 | → |
| The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery. | Blum K et al. | — | 2015 | → |
| Association of CREB1 gene polymorphism with drug seeking behaviour in eastern Indian addicts. | Pal A et al. | — | 2014 | → |
| Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. | Uhl GR et al. | — | 2014 | → |
| Suicidal behavior and haplotypes of the dopamine receptor gene (DRD2) and ANKK1 gene polymorphisms in patients with alcohol dependence--preliminary report. | Jasiewicz A et al. | — | 2014 | → |
| Estimation of BDNF gene polymorphism and predisposition to dependence development for selected psychoactive compounds: genetic aspects of addiction with the selected drugs, amphetamine, tetrahydrocannabinol and opiates. | Biskupska J et al. | — | 2013 | → |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | — | 2013 | → |
| Analysis of dopamine D2 receptor (DRD2) gene polymorphisms in cannabinoid addicts. | Nacak M et al. | — | 2012 | → |
| Illicit drug use in heavy smokers with and without schizophrenia. | Mackowick KM et al. | — | 2012 | → |
| Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. | Teh LK et al. | — | 2012 | → |
| Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. | Johnson C et al. | — | 2011 | → |
| "Replicated" genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs. | Drgon T et al. | — | 2011 | → |
| Genome wide association for addiction: replicated results and comparisons of two analytic approaches. | Drgon T et al. | — | 2010 | → |
| Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. | Willeit M et al. | — | 2010 | → |
| The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. | Clague J et al. | — | 2010 | → |
| Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence. | Uhl GR et al. | — | 2009 | → |
| Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis. | Ujike H et al. | — | 2009 | → |
| Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. | Drgon T et al. | — | 2009 | → |
| Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes. | Drgon T et al. | — | 2009 | → |
| Addiction Reviews. Preface. | Uhl GR | — | 2008 | → |
| Association of PTPRB gene polymorphism with drug addiction. | Ishiguro H et al. | — | 2008 | → |
| Dopaminergic mutations: within-family association and linkage in multiplex alcohol dependence families. | Hill SY et al. | — | 2008 | → |
| Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples. | Johnson C et al. | — | 2008 | → |
| "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. | Uhl GR et al. | — | 2008 | → |
| Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. | Uhl GR et al. | — | 2008 | → |
| Heavy nicotine and alcohol use in alcohol dependence is associated with D2 dopamine receptor (DRD2) polymorphism. | Connor JP et al. | — | 2007 | → |
| Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs. | Uhl GR et al. | — | 2007 | → |
| Overview of the pharmacogenomics of cigarette smoking. | Ho MK et al. | — | 2007 | → |
| Premature poking: impulsivity, cocaine and dopamine. | Uhl G | — | 2007 | → |
| Temperament and character dimensions in opiate addicts: comparing subjects who completed inpatient treatment in therapeutic communities vs. incompleters. | Zoccali R et al. | — | 2007 | → |
| Variation in a bicarbonate co-transporter gene family member SLC4A7 is associated with propensity to addictions: a study using fine-mapping and three samples. | Ishiguro H et al. | — | 2007 | → |
| Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes. | Liu QR et al. | — | 2006 | → |
| NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. | Ishiguro H et al. | — | 2006 | → |
| Association between the DRD2 A1 allele and opium addiction in the Iranian population. | Shahmoradgoli Najafabadi M et al. | — | 2005 | → |
| Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence. | Messas G et al. | — | 2005 | → |
| DRD2 genotypes and substance use in adolescent children of alcoholics. | Conner BT et al. | — | 2005 | → |
| Family history of alcoholism and response to amphetamine: sex differences in the effect of risk. | Gabbay FH | — | 2005 | → |
| Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking. | Caron L et al. | — | 2005 | → |
| Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples. | Liu QR et al. | — | 2005 | → |
| ADH1B*1, ADH1C*2, DRD2 (-141C Ins), and 5-HTTLPR are associated with alcoholism in Mexican American men living in Los Angeles. | Konishi T et al. | — | 2004 | → |
| Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene. | Young RM et al. | — | 2004 | → |
| Genetics of tobacco use. | Maserejian NN et al. | — | 2004 | → |
| Molecular genetic underpinnings of human substance abuse vulnerability: likely contributions to understanding addiction as a mnemonic process. | Uhl GR | — | 2004 | → |
| Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA(A) receptor beta(3) subunit genes and alcoholism in Mexican-Americans. | Konishi T et al. | — | 2004 | → |
| The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse. | Lin Z et al. | — | 2004 | → |
| Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. | Ritchie T et al. | — | 2003 | → |
| D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. | Noble EP | — | 2003 | → |
| Differential associations of sex and D2 dopamine receptor (DRD2) genotype with negative affect and other substance abuse risk markers in children of alcoholics. | Berman SM et al. | — | 2003 | → |
| Dopamine D2 receptor binding, Drd2 expression and the number of dopamine neurons in the BXD recombinant inbred series: genetic relationships to alcohol and other drug associated phenotypes. | Hitzemann R et al. | — | 2003 | → |
| Genetic influences on smoking behavior and nicotine dependence: a review. | Yoshimasu K et al. | — | 2003 | → |
| Heroin addiction in Saudi Arabia--not merely a behavioural problem. | Osman A et al. | — | 2003 | → |
| The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? | Moolchan ET et al. | — | 2002 | → |
| Genetic determinants of alcohol addiction and metabolism: a survey in Italy. | Pastorelli R et al. | — | 2001 | → |
| Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. | Rana BK et al. | — | 2001 | → |
| Imaging neurochemical endophenotypes: promises and pitfalls. | Martinez D et al. | — | 2001 | → |
| Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. | Uhl GR et al. | — | 2001 | → |
| Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. | Noble EP | — | 2000 | → |
| An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression. | Zimprich A et al. | — | 2000 | → |
| Co-occurring risk factors for alcohol dependence and habitual smoking. | Bierut LJ et al. | — | 2000 | → |
| Family-based study of DRD2 alleles in alcohol and drug dependence. | Blomqvist O et al. | — | 2000 | → |
| Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. | Bierut LJ et al. | — | 2000 | → |
| Genetic studies of substance abuse. | Vanyukov MM et al. | — | 2000 | → |
| Genetic vulnerability to drug abuse. | Duaux E et al. | — | 2000 | → |
| Haplotypes at the DRD2 locus and severe alcoholism. | Noble EP et al. | — | 2000 | → |
| Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. | Vandenbergh DJ et al. | — | 2000 | → |
| Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: no interaction with functional alleles of the catechol-o-methyltransferase (COMT) gene. | Vandenbergh DJ et al. | — | 2000 | → |
| Pharmacogenomics and addiction to opiates. | Lichtermann D et al. | — | 2000 | → |
| Polymorphisms in dopamine receptors: what do they tell us? | Wong AH et al. | — | 2000 | → |
| Reappraisal of the association between the DRD2 gene, alcoholism and addiction. | Gorwood P et al. | — | 2000 | → |
| Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. | Blum K et al. | — | 2000 | → |
| The DRD2 gene and the risk for alcohol dependence in bipolar patients. | Gorwood P et al. | — | 2000 | → |
| The DRD2 gene in psychiatric and neurological disorders and its phenotypes. | Noble EP | — | 2000 | → |
| Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. | Town T et al. | — | 1999 | → |
| Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins. | Kendler KS et al. | — | 1999 | → |
| Implications of genetic epidemiology for the prevention of tobacco use. | Swan GE | — | 1999 | → |
| No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans. | Gelernter J et al. | — | 1999 | → |
| Polymorphism of dopamine D2 and D4 receptor genes and Slavic-surnamed alcoholic patients. | Ovchinnikov IV et al. | — | 1999 | → |
| The DRD2A₁allele: a behavioural genetic risk factor in hepatitis C infection of persistent drug abusers. | Lawford B et al. | — | 1999 | → |
| A family-based analysis of the association of the dopamine D2 receptor (DRD2) with alcoholism. | Edenberg HJ et al. | — | 1998 | → |
| Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. | Spitz MR et al. | — | 1998 | → |
| Cocaine use, abuse and dependence in a population-based sample of female twins. | Kendler KS et al. | — | 1998 | → |
| Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. | Peroutka SJ et al. | — | 1998 | → |
| D2 dopamine receptor and GABA(A) receptor beta3 subunit genes and alcoholism. | Noble EP et al. | — | 1998 | → |
| Step-wise analysis of polymorphisms in the human dopamine D2 receptor gene. | Jones KW et al. | — | 1998 | → |
| The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. | Noble EP | — | 1998 | → |
| The dopamine D2 receptor gene TaqI A polymorphism is not associated with Novelty Seeking, Harm Avoidance and Reward Dependence in healthy subjects. | de Brettes B et al. | — | 1998 | → |
| Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. | Comings DE | — | 1998 | → |
| Association of the D2 dopamine receptor A1 allele with alcoholism: medical severity of alcoholism and type of controls. | Lawford BR et al. | — | 1997 | → |
| Dopamine D2 receptor gene and alcoholism among four aboriginal groups and Han in Taiwan. | Chen WJ et al. | — | 1997 | → |
| High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. | Vandenbergh DJ et al. | — | 1997 | → |
| The D2 dopamine receptor (DRD2) gene and family stress; interactive effects on cognitive functions in children. | Berman SM et al. | — | 1997 | → |
| The medical utility of genomics data in neuropsychiatry: mutational genetics versus association genetics. | Peroutka SJ | — | 1997 | → |
| A genetic linkage study of the D2 dopamine receptor locus in heavy drinking and alcoholism. | Cook CC et al. | — | 1996 | → |
| Alcoholism and the dopaminergic system: a review. | Noble EP | — | 1996 | → |
| D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. | Persico AM et al. | — | 1996 | → |
| Direct analysis of candidate genes in impulsive behaviours. | Goldman D et al. | — | 1996 | → |
| Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication. | Comings DE et al. | — | 1996 | → |
| Dopamine D2 receptor (DRD2) genotype differentiates intravenous drug abusers from alcoholics and non-abusers. | Foley PF et al. | — | 1996 | → |
| Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans. | Berrettini WH et al. | — | 1996 | → |
| Functional analysis of the human D2 dopamine receptor missense variants. | Cravchik A et al. | — | 1996 | → |
| Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. | Comings DE et al. | — | 1996 | → |
| Reduced dopaminergic function in alcoholics is related to severe dependence. | Schmidt LG et al. | — | 1996 | → |
| Substance use disorder exacerbates brain electrophysiological abnormalities in a psychiatrically-ill population. | Braverman ER et al. | — | 1996 | → |
| The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis. | Swan GE et al. | — | 1996 | → |
| The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. | Blum K et al. | — | 1996 | → |
| Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. | Tiihonen J et al. | — | 1995 | → |
| Association and linkage studies of the TAQI A1 allele at the dopamine D2 receptor gene in samples of female and male alcoholics. | Neiswanger K et al. | — | 1995 | → |
| Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. | Lawford BR et al. | — | 1995 | → |
| Dopamine D2 receptor gene (DRD2) haplotypes and the defense style questionnaire in substance abuse, Tourette syndrome, and controls. | Comings DE et al. | — | 1995 | → |
| Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics: a reappraisal. | Blum K et al. | — | 1995 | → |
| Gene Variability and Vulnerability to Alcoholism. | Doria JJ | — | 1995 | → |
| Homovanillic acid and dopamine-beta-hydroxylase in male youth: relationships with paternal substance abuse and antisocial behavior. | Gabel S et al. | — | 1995 | → |
| Identifying alcoholism vulnerability alleles. | Goldman D | — | 1995 | → |
| Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence. | Pomerleau OF | — | 1995 | → |
| Personality dimensions of opiate addicts. | Vukov M et al. | — | 1995 | → |
| Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAOA gene with early onset alcoholism/substance abuse. | Vanyukov MM et al. | — | 1995 | → |
| What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics? | Neiswanger K et al. | — | 1995 | → |
| Alcoholism research. A cautionary genetic tale: the sobering story of D2. | Holden C | — | 1994 | → |
| D2 dopamine receptor gene and cigarette smoking: a reward gene? | Noble EP et al. | — | 1994 | → |
| D2 dopamine receptor gene and obesity. | Noble EP et al. | — | 1994 | → |
| Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. | Geijer T et al. | — | 1994 | → |
| Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse. | Comings DE | — | 1994 | → |
| Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains. | Ng GY et al. | — | 1994 | → |
| Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. | Wang JB et al. | — | 1994 | → |
| Localization of the dopamine transporter gene, Dat1, on mouse chromosome 13. | Lossie AC et al. | — | 1994 | → |
| Monoamine oxidase and homovanillic acid in boys with predispositions to substance abuse. | Gabel S et al. | — | 1994 | → |
| The dopamine D2 receptor gene: a genetic risk factor in substance abuse. | Comings DE et al. | — | 1994 | → |
| A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPs. | Surratt CK et al. | — | 1993 | → |
| Allelic association of the D2 dopamine receptor gene with cocaine dependence. | Noble EP et al. | — | 1993 | → |
| Comorbid psychopathy is not associated with increased D2 dopamine receptor TaqI A or B gene marker frequencies in incarcerated substance abusers. | Smith SS et al. | — | 1993 | → |
| Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. | Persico AM et al. | — | 1993 | → |
| Substance abuse vulnerability and D2 receptor genes. | Uhl G et al. | — | 1993 | → |
| The D2 dopamine receptor gene: a review of association studies in alcoholism. | Noble EP | — | 1993 | → |
| A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. | Vandenbergh DJ et al. | — | 1992 | → |
| Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. | Vandenbergh DJ et al. | — | 1992 | → |